ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.11%84.540.9%$1038.70m
KITEKite Pharma, Inc.
0.18%179.6316.1%$788.56m
CELGCelgene Corporation
-0.46%144.271.1%$523.72m
AMGNAmgen Inc.
-0.09%186.131.1%$498.94m
BIIBBiogen Inc.
-0.20%316.871.2%$435.14m
REGNRegeneron Pharmaceuticals, Inc.
-0.35%436.632.7%$369.01m
ALNYAlnylam Pharmaceuticals, Inc
-4.18%112.1510.7%$259.01m
ALXNAlexion Pharmaceuticals, Inc.
-2.50%140.361.9%$232.49m
JUNOJuno Therapeutics, Inc.
-1.37%41.7514.6%$228.36m
INCYIncyte Corporation
-0.57%109.072.6%$223.78m
VRTXVertex Pharmaceuticals Incorporated
0.26%149.481.9%$216.88m
ILMNIllumina, Inc.
-1.24%198.883.5%$163.00m
BLUEBluebird Bio, Inc.
-2.32%127.4719.3%$145.91m
BMRNBioMarin Pharmaceutical Inc.
-1.24%93.224.4%$140.71m
CLVSClovis Oncology, Inc.
-3.08%73.6218.0%$133.33m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.